# PVH Corp.: financial statements, quarterly

PVH · NYSE · CIK 78239 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/pvh.md) · [Financials](/companies/pvh/financials.md) · [Filings](/companies/pvh/filings.md) · [Insiders](/companies/pvh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pvh/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-29) | Q4 FY2023 (2024-02-04) | Q1 FY2024 (2024-05-05) | Q2 FY2024 (2024-08-04) | Q3 FY2024 (2024-11-03) | Q4 FY2024 (2025-02-02) | Q1 FY2025 (2025-05-04) | Q2 FY2025 (2025-08-03) | Q3 FY2025 (2025-11-02) | Q4 FY2025 (2026-02-01) | Q1 FY2026 (2026-05-03) | Q2 FY2026 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,363](/filings/0000078239-24-000089.md) | [2,490 d](/filings/0000078239-26-000021.md) | [1,952](/filings/0000078239-25-000052.md) | [2,074](/filings/0000078239-25-000072.md) | [2,255](/filings/0000078239-25-000090.md) | [2,372 d](/filings/0000078239-26-000021.md) | [1,984](/filings/0000078239-26-000040.md) | [2,167](/filings/0000078239-26-000056.md) | [2,294](/filings/0000078239-25-000090.md) | [2,505 d](/filings/0000078239-26-000021.md) | [2,025](/filings/0000078239-26-000040.md) | [2,097](/filings/0000078239-26-000056.md) |
| Cost of revenue | $m | [1,024](/filings/0000078239-24-000089.md) | [989 d](/filings/0000078239-26-000021.md) | [753](/filings/0000078239-25-000052.md) | [828](/filings/0000078239-25-000072.md) | [939](/filings/0000078239-25-000090.md) | [990 d](/filings/0000078239-26-000021.md) | [822](/filings/0000078239-26-000040.md) | [916](/filings/0000078239-26-000056.md) | [1,002](/filings/0000078239-25-000090.md) | [1,062 d](/filings/0000078239-26-000021.md) | [839](/filings/0000078239-26-000040.md) | [775](/filings/0000078239-26-000056.md) |
| Gross profit | $m | [1,339](/filings/0000078239-24-000089.md) | [1,501 d](/filings/0000078239-26-000021.md) | [1,199](/filings/0000078239-25-000052.md) | [1,246](/filings/0000078239-25-000072.md) | [1,317](/filings/0000078239-25-000090.md) | [1,381 d](/filings/0000078239-26-000021.md) | [1,162](/filings/0000078239-26-000040.md) | [1,251](/filings/0000078239-26-000056.md) | [1,293](/filings/0000078239-25-000090.md) | [1,443 d](/filings/0000078239-26-000021.md) | [1,186](/filings/0000078239-26-000040.md) | [1,322](/filings/0000078239-26-000056.md) |
| Selling, general and administrative | $m | [1,124](/filings/0000078239-24-000089.md) | [1,216 d](/filings/0000078239-26-000021.md) | [1,017](/filings/0000078239-25-000052.md) | [1,083](/filings/0000078239-25-000072.md) | [1,154](/filings/0000078239-25-000090.md) | [1,157 d](/filings/0000078239-26-000021.md) | [1,024](/filings/0000078239-26-000040.md) | [1,129](/filings/0000078239-26-000056.md) | [1,121](/filings/0000078239-25-000090.md) | [1,218 d](/filings/0000078239-26-000021.md) | [1,074](/filings/0000078239-26-000040.md) | [1,113](/filings/0000078239-26-000056.md) |
| Operating income | $m | [230](/filings/0000078239-24-000089.md) | [357 d](/filings/0000078239-26-000021.md) | [205](/filings/0000078239-25-000052.md) | [174](/filings/0000078239-25-000072.md) | [183](/filings/0000078239-25-000090.md) | [210 d](/filings/0000078239-26-000021.md) | [(332)](/filings/0000078239-26-000040.md) | [133](/filings/0000078239-26-000056.md) | [181](/filings/0000078239-25-000090.md) | [249 d](/filings/0000078239-26-000021.md) | [124](/filings/0000078239-26-000040.md) | [(191)](/filings/0000078239-26-000056.md) |
| Interest expense | $m | [24.3](/filings/0000078239-24-000089.md) | [23.8 d](/filings/0000078239-26-000021.md) | [23.3](/filings/0000078239-25-000052.md) | [22.8](/filings/0000078239-25-000072.md) | [23.0](/filings/0000078239-25-000090.md) | [20.7 d](/filings/0000078239-26-000021.md) | [22.4](/filings/0000078239-26-000040.md) | [25.8](/filings/0000078239-26-000056.md) | [23.2](/filings/0000078239-25-000090.md) | [22.8 d](/filings/0000078239-26-000021.md) | [22.7](/filings/0000078239-26-000040.md) | [22.3](/filings/0000078239-26-000056.md) |
| Income tax | $m | [46.0](/filings/0000078239-24-000089.md) | [65.1 d](/filings/0000078239-26-000021.md) | [36.0](/filings/0000078239-25-000052.md) | [(3.2)](/filings/0000078239-25-000072.md) | [35.1](/filings/0000078239-25-000090.md) | [39.3 d](/filings/0000078239-26-000021.md) | [(305)](/filings/0000078239-26-000040.md) | [(113)](/filings/0000078239-26-000056.md) | [156](/filings/0000078239-25-000090.md) | [388 d](/filings/0000078239-26-000021.md) | [20.5](/filings/0000078239-26-000040.md) | [(99.7)](/filings/0000078239-26-000056.md) |
| Net income | $m | [162](/filings/0000078239-24-000089.md) | [272 d](/filings/0000078239-26-000021.md) | [151](/filings/0000078239-25-000090.md) | [158](/filings/0000078239-25-000090.md) | [132](/filings/0000078239-25-000090.md) | [157 d](/filings/0000078239-26-000021.md) | [(44.8)](/filings/0000078239-26-000056.md) | [224](/filings/0000078239-26-000056.md) | [4.2](/filings/0000078239-25-000090.md) | [(158) d](/filings/0000078239-26-000021.md) | [88.0](/filings/0000078239-26-000056.md) | [(103)](/filings/0000078239-26-000056.md) |
| Diluted EPS | $ per share | [2.66](/filings/0000078239-24-000089.md) | not reported | [2.59](/filings/0000078239-25-000052.md) | [2.80](/filings/0000078239-25-000072.md) | [2.34](/filings/0000078239-25-000090.md) | not reported | [(0.88)](/filings/0000078239-26-000040.md) | [4.63](/filings/0000078239-26-000056.md) | [0.09](/filings/0000078239-25-000090.md) | not reported | [1.90](/filings/0000078239-26-000040.md) | [(2.23)](/filings/0000078239-26-000056.md) |
| Basic EPS | $ per share | [2.68](/filings/0000078239-24-000089.md) | not reported | [2.63](/filings/0000078239-25-000052.md) | [2.83](/filings/0000078239-25-000072.md) | [2.37](/filings/0000078239-25-000090.md) | not reported | [(0.88)](/filings/0000078239-26-000040.md) | [4.66](/filings/0000078239-26-000056.md) | [0.09](/filings/0000078239-25-000090.md) | not reported | [1.92](/filings/0000078239-26-000040.md) | [(2.23)](/filings/0000078239-26-000056.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-29) | FY2023 (2024-02-04) | Q1 FY2024 (2024-05-05) | Q2 FY2024 (2024-08-04) | Q3 FY2024 (2024-11-03) | FY2024 (2025-02-02) | Q1 FY2025 (2025-05-04) | Q2 FY2025 (2025-08-03) | Q3 FY2025 (2025-11-02) | FY2025 (2026-02-01) | Q1 FY2026 (2026-05-03) | Q2 FY2026 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.4](/filings/0000078239-24-000089.md) | [0.7](/filings/0000078239-25-000018.md) | [0.4](/filings/0000078239-25-000052.md) | [0.6](/filings/0000078239-25-000072.md) | [0.6](/filings/0000078239-25-000090.md) | [0.7](/filings/0000078239-26-000021.md) | [0.2](/filings/0000078239-26-000040.md) | [0.2](/filings/0000078239-26-000056.md) | [0.2](/filings/0000078239-25-000090.md) | [0.7](/filings/0000078239-26-000056.md) | [0.6](/filings/0000078239-26-000040.md) | [1.0](/filings/0000078239-26-000056.md) |
| Current assets | $bn | [3.3](/filings/0000078239-24-000089.md) | [3.3](/filings/0000078239-25-000018.md) | [2.9](/filings/0000078239-25-000052.md) | [3.4](/filings/0000078239-25-000072.md) | [3.5](/filings/0000078239-25-000090.md) | [3.5](/filings/0000078239-26-000021.md) | [3.0](/filings/0000078239-26-000040.md) | [3.3](/filings/0000078239-26-000056.md) | [3.3](/filings/0000078239-25-000090.md) | [3.6](/filings/0000078239-26-000056.md) | [3.4](/filings/0000078239-26-000040.md) | [4.0](/filings/0000078239-26-000056.md) |
| Total assets | $bn | [11.2](/filings/0000078239-24-000089.md) | [11.2](/filings/0000078239-26-000021.md) | [10.8](/filings/0000078239-25-000052.md) | [11.2](/filings/0000078239-25-000072.md) | [11.2](/filings/0000078239-25-000090.md) | [11.0](/filings/0000078239-26-000021.md) | [10.7](/filings/0000078239-26-000040.md) | [11.6](/filings/0000078239-26-000056.md) | [11.4](/filings/0000078239-25-000090.md) | [11.7](/filings/0000078239-26-000056.md) | [11.3](/filings/0000078239-26-000040.md) | [11.4](/filings/0000078239-26-000056.md) |
| Current liabilities | $bn | [2.8](/filings/0000078239-24-000089.md) | [2.8](/filings/0000078239-25-000018.md) | [1.9](/filings/0000078239-25-000052.md) | [2.8](/filings/0000078239-25-000072.md) | [2.7](/filings/0000078239-25-000090.md) | [2.7](/filings/0000078239-26-000021.md) | [2.7](/filings/0000078239-26-000040.md) | [2.4](/filings/0000078239-26-000056.md) | [2.2](/filings/0000078239-25-000090.md) | [2.4](/filings/0000078239-26-000056.md) | [2.0](/filings/0000078239-26-000040.md) | [2.4](/filings/0000078239-26-000056.md) |
| Long-term debt | $bn | [1.6](/filings/0000078239-24-000089.md) | [1.6](/filings/0000078239-25-000018.md) | [2.1](/filings/0000078239-25-000052.md) | [1.7](/filings/0000078239-25-000072.md) | [1.7](/filings/0000078239-25-000090.md) | [1.6](/filings/0000078239-26-000021.md) | [1.7](/filings/0000078239-26-000040.md) | [2.3](/filings/0000078239-26-000056.md) | [2.2](/filings/0000078239-25-000090.md) | [2.3](/filings/0000078239-26-000056.md) | [2.3](/filings/0000078239-26-000040.md) | [2.2](/filings/0000078239-26-000056.md) |
| Current portion of debt | $bn | [0.7](/filings/0000078239-24-000089.md) | [0.6](/filings/0000078239-25-000018.md) | [0.0](/filings/0000078239-25-000052.md) | [0.5](/filings/0000078239-25-000072.md) | [0.5](/filings/0000078239-25-000090.md) | [0.5](/filings/0000078239-26-000021.md) | [0.5](/filings/0000078239-26-000040.md) | [0.0](/filings/0000078239-26-000056.md) | [0.0](/filings/0000078239-25-000090.md) | [0.0](/filings/0000078239-26-000056.md) | [0.0](/filings/0000078239-26-000040.md) | [0.0](/filings/0000078239-26-000056.md) |
| Short-term borrowings | $bn | [0.0](/filings/0000078239-24-000089.md) | [0.0](/filings/0000078239-25-000018.md) | [0.0](/filings/0000078239-25-000052.md) | [0.0](/filings/0000078239-25-000072.md) | [0.0](/filings/0000078239-25-000090.md) | [0.0](/filings/0000078239-26-000021.md) | [0.1](/filings/0000078239-26-000040.md) | [0.0](/filings/0000078239-26-000056.md) | [0.0](/filings/0000078239-25-000090.md) | [0.0](/filings/0000078239-26-000056.md) | [0.0](/filings/0000078239-26-000040.md) | [0.0](/filings/0000078239-26-000056.md) |
| Shareholders' equity | $bn | [5.1](/filings/0000078239-24-000089.md) | [5.1](/filings/0000078239-26-000021.md) | [5.1](/filings/0000078239-25-000090.md) | [5.2](/filings/0000078239-25-000090.md) | [5.3](/filings/0000078239-25-000090.md) | [5.1](/filings/0000078239-26-000056.md) | [4.6](/filings/0000078239-26-000056.md) | [4.9](/filings/0000078239-26-000056.md) | [4.9](/filings/0000078239-25-000090.md) | [4.8](/filings/0000078239-26-000056.md) | [4.9](/filings/0000078239-26-000056.md) | [4.8](/filings/0000078239-26-000056.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-29) | Q4 FY2023 (2024-02-04) | Q1 FY2024 (2024-05-05) | Q2 FY2024 (2024-08-04) | Q3 FY2024 (2024-11-03) | Q4 FY2024 (2025-02-02) | Q1 FY2025 (2025-05-04) | Q2 FY2025 (2025-08-03) | Q3 FY2025 (2025-11-02) | Q4 FY2025 (2026-02-01) | Q1 FY2026 (2026-05-03) | Q2 FY2026 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [116 d](/filings/0000078239-24-000089.md) | [658 d](/filings/0000078239-26-000021.md) | [(66.7)](/filings/0000078239-25-000052.md) | [292 d](/filings/0000078239-25-000072.md) | [28.7 d](/filings/0000078239-25-000090.md) | [487 d](/filings/0000078239-26-000021.md) | [(71.4)](/filings/0000078239-26-000040.md) | [213 d](/filings/0000078239-26-000056.md) | [(44.5) d](/filings/0000078239-25-000090.md) | [583 d](/filings/0000078239-26-000021.md) | [(46.5)](/filings/0000078239-26-000040.md) | [383 d](/filings/0000078239-26-000056.md) |
| Capital expenditure | $m | [47.4 d](/filings/0000078239-24-000089.md) | [81.4 d](/filings/0000078239-26-000021.md) | [38.8](/filings/0000078239-25-000052.md) | [36.6 d](/filings/0000078239-25-000072.md) | [40.0 d](/filings/0000078239-25-000090.md) | [43.3 d](/filings/0000078239-26-000021.md) | [26.7](/filings/0000078239-26-000040.md) | [31.2 d](/filings/0000078239-26-000056.md) | [40.6 d](/filings/0000078239-25-000090.md) | [43.5 d](/filings/0000078239-26-000021.md) | [39.5](/filings/0000078239-26-000040.md) | [36.5 d](/filings/0000078239-26-000056.md) |
| Share repurchases | $m | [72.5 d](/filings/0000078239-24-000089.md) | [284 d](/filings/0000078239-26-000021.md) | [214](/filings/0000078239-25-000052.md) | [31.4 d](/filings/0000078239-25-000072.md) | [34.8 d](/filings/0000078239-25-000090.md) | [245 d](/filings/0000078239-26-000021.md) | [572](/filings/0000078239-26-000040.md) | [4.8 d](/filings/0000078239-26-000056.md) | [0.2 d](/filings/0000078239-25-000090.md) | [0.5 d](/filings/0000078239-26-000021.md) | [14.9](/filings/0000078239-26-000040.md) | [2.0 d](/filings/0000078239-26-000056.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-30) | Q1 FY2023 (2023-04-30) | Q2 FY2023 (2023-07-30) | Q3 FY2023 (2023-10-29) | Q1 FY2024 (2024-05-05) | Q2 FY2024 (2024-08-04) | Q3 FY2024 (2024-11-03) | Q1 FY2025 (2025-05-04) | Q2 FY2025 (2025-08-03) | Q3 FY2025 (2025-11-02) | Q1 FY2026 (2026-05-03) | Q2 FY2026 (2026-08-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [64.8](/filings/0000078239-23-000135.md) | [63.5](/filings/0000078239-24-000042.md) | [62.7](/filings/0000078239-24-000074.md) | [60.8](/filings/0000078239-24-000089.md) | [58.4](/filings/0000078239-25-000052.md) | [56.5](/filings/0000078239-25-000072.md) | [56.3](/filings/0000078239-25-000090.md) | [51.1](/filings/0000078239-26-000040.md) | [48.5](/filings/0000078239-26-000056.md) | [47.9](/filings/0000078239-25-000090.md) | [46.4](/filings/0000078239-26-000040.md) | [46.1](/filings/0000078239-26-000056.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 46,137,833 at 2026-08-26, from the cover of the [10-Q filed 2026-09-02](/filings/0000078239-26-000056.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.